Mohammad AskarPublic working copy · medical review pending

Retina · 015

Macular hole: OCT assessment, repair and vitreoretinal foundations

Start with the central retinal defect, then connect the repair to its evidence and the person’s needs. Retained broader surgical topics are clearly separated by indication.

Working copy published: 2026-11-06T03:47:16+01:00. Source, translation and medical checks remain open. Limitations are stated in the text and references. Editorial text version: 2026-11-04 23:43 CET.

Confirm a full-thickness hole on OCT, describe size, traction and cause, and distinguish anatomical closure from visual recovery. Agree positioning, gas precautions and follow-up before surgery.

Terminology and draft status

Selected Arabic terms were directly checked in WHO UMD; exact matches and unresolved compounds are recorded in the terminology ledger. Remaining compounds and full clinical translations remain working copies for further review. Source and medical checks remain pending.

01Confirm a full-thickness hole and identify its cause

A full-thickness macular hole (FTMH) interrupts the neurosensory retina at the fovea and can cause central blur, distortion and a central scotoma. The retinal pigment epithelium beneath it is not part of the missing neurosensory tissue. 1 2

Primary holes arise from vitreomacular traction, often during age-related vitreous separation. Trauma, high myopia and other macular disease can produce secondary holes; a highly myopic eye needs assessment for associated schisis or retinal detachment. 1 2

Ask about symptom duration, distortion, previous operations or trauma and the effect on reading and daily tasks. Examine refraction, visual acuity, lens, vitreoretinal interface and peripheral retina, and assess the fellow eye. 1

A lamellar hole leaves some retinal tissue intact, while a pseudohole may be shaped by an epiretinal membrane without a full-thickness defect. Macular oedema, MacTel and other central lesions can also resemble a hole; one dark OCT space is not sufficient for diagnosis. 1 2

02Measure the OCT defect and describe the vitreous

Inspect several closely spaced OCT scans so a small hole or residual vitreous attachment is not missed. Measure minimum linear diameter at the narrowest aperture with a line roughly parallel to the retinal pigment epithelium, rather than using the wider basal diameter. 1 2

The International Vitreomacular Traction Study (IVTS) table defines small holes as ≤250 µm, medium holes as >250–≤400 µm and large holes as >400 µm. Also report whether vitreomacular traction (VMT) is present and whether the hole is primary or secondary. 2

Vitreomacular adhesion (VMA) is residual attachment without disturbed foveal morphology; VMT includes structural distortion. An impending hole is not already a full-thickness defect, and a Gass stage is not interchangeable with an IVTS size group. 2

Size, symptom duration, baseline function, outer-retinal damage and previous repair affect counselling. Anatomical closure can occur without normal visual recovery; persistent ellipsoid-zone damage may help explain residual distortion. 1 2

Measure the OCT defect and describe the vitreous
IVTS sizeMinimum apertureInterpretation
Small≤250 µmReport traction, cause and clinical context as well.
Medium>250–≤400 µmDo not substitute basal diameter or a Gass stage.
Large>400 µmSize affects prognosis; it is not an absolute technique mandate.

03Choose repair and explain what the evidence measures

Discuss observation versus surgery in the actual clinical context: selected small or traumatic holes may close, whereas delay can reduce the chance of a good outcome. A symptomatic established primary hole merits timely vitreoretinal assessment rather than a blanket waiting period. 1

Pars plana vitrectomy (PPV), release of residual posterior hyaloid traction, usually internal limiting membrane (ILM) peeling and a selected tamponade form an established repair strategy. The ILM is the innermost retinal boundary; its removal can reduce residual traction but also alters inner-retinal structure. 1

FILMS randomised 141 people with stage 2–3 idiopathic holes; 127 completed 6 months. The primary distance-vision difference was 4.8 letters (95% CI −0.3–9.8; p=0.063), while 1-month closure was 84% with ILM peeling versus 48% without it. 3

Reoperation by 6 months was 12% versus 48%. These anatomical and repeat-surgery advantages do not prove the same visual benefit for every hole, and the combined phacovitrectomy trial does not compare every current flap technique. 3

An inverted ILM flap, free tissue or another rescue method may be considered for selected large, chronic, highly myopic or previously operated holes. Flap coverage, insertion and amniotic membrane are different interventions; one method cannot inherit another method’s evidence. 1 6 7

InFlap included 99 eyes to conventional peeling or a perfluoro-octane-assisted inverted flap. The primary 3-month closure result did not differ; a 6-month difference was not maintained at 12 months, and visual acuity did not differ between groups. 6

A 2025 trial compared iOCT-guided partial peeling with an inferior flap against standard peeling in 34 eyes; a separate amniotic-membrane comparison enrolled 23 people with 25 large or refractory holes. Small samples, selected techniques and limited precision prevent claims of universal superiority, equivalence or established safety. 7 8

04Agree a feasible position and keep gas precautions distinct

Discuss the intended gas fill, hole size, repair technique and the person’s ability to posture before surgery. Face-forward positioning in a trial is not unrestricted activity or permission to lie face up; follow the operating team’s specific instructions. 1 4 5

PIMS studied holes ≥400 µm with ILM peeling and 14% C3F8, comparing advice for face-down versus face-forward positioning for 8 hours daily over 5 days. Of 185 randomised participants, 178 were analysed; 3-month closure was 84/88 versus 77/90 (95.5% versus 85.6%). 4

The adjusted odds ratio was 3.15 (95% CI 0.87–11.41; p=0.08), so superiority was not established and a smaller benefit remains possible. OCT grading was masked, but adherence was unmeasured; secondary visual findings and several analyses do not settle the primary closure question. 4

The 2023 Cochrane review pooled 8 trials with 709 eyes: closure RR 1.05 (95% CI 0.99–1.12), with low certainty. Different operations, positioning regimens and uncertain adherence limit a universal prescription; PIMS is part of this evidence, not an independent extra pooled result. 5

Do not fly while an intraocular gas bubble remains, and discuss altitude travel with the team. Nitrous oxide, including emergency “gas and air” analgesia, can expand the bubble and dangerously raise pressure; tell every treating clinician and carry the gas warning information. 9

05Plan recovery, cataract counselling and urgent access

Explain that a closed hole is an anatomical result and visual recovery can be slower or incomplete. Cataract commonly progresses in phakic eyes after PPV; combined versus later cataract surgery depends on the eye and the person’s needs. 1

Arrange postoperative visual acuity, pressure, anterior-segment, peripheral-retinal and OCT review according to risk and the operation. The 2026 RCOphth day-one guidance is conditional and based on very-low-certainty evidence; it is not permission to omit review for every gas-filled, glaucomatous or complicated eye. 1 10

Discuss new distortion or central blur in the fellow eye and how to obtain prompt assessment. A complete vitreous separation changes fellow-eye risk; a normal-looking fellow eye is not a lifetime guarantee. 1

Severe or increasing pain, increasing redness or marked visual loss after surgery requires urgent ophthalmic assessment. New flashes, many floaters or a curtain or field shadow also warrant prompt examination for a retinal tear or detachment. 1 9

06Surgical foundations: history and pressure balance

The following surgical teaching sections retain the original broader PPV and laser topics. Endophthalmitis, diabetic tractional detachment, choroidal bleeding and PRP are separate indications, not routine stages of macular-hole repair. 1 11

The original historical sequence names Kasner’s open-sky work in 1961, Machemer’s closed VISC system in 1970 and O’Malley’s 3-port approach. These remain historical teaching attributions with unresolved original dates and priority, not verified personal surgical experience. 11

Separating infusion, illumination and working instruments allows controlled access and fluid management. Loss of infusion or excessive outflow can cause hypotony; neither the number of ports alone nor an unverified fixed pressure guarantees globe stability. 11

The original sequence runs from 17G to 23G, 25G and 27G. Gauge affects access, flow and instrument behaviour, but current model design, wound construction and the task matter more than an absolute “large for complex, small for simple” rule. 11

07Choose instruments and maintain a useful view

For firm diabetic membranes, consider instrument rigidity, available scissors and forceps, access and the intended dissection. A 27G instrument is not automatically inadequate, nor are all 23G or 25G instruments interchangeable. 11

The original viewing examples are wide-angle BIOM and Resight for peripheral work and contact lenses for macular detail. Choose a view that permits the required manoeuvre; lens magnification, stereopsis and illumination do not establish universal superiority or current product eligibility. 1 11

The original 20,000 cpm example has a device-specific counterpart: the 2022 EVA NEXUS submission describes TDC cutters driven at 10,000 cycles/min, cutting on both strokes. Effective cuts/min and mechanical cycles/min must not be treated as the same measurement. 11

Port geometry, duty cycle, aspiration, distance to the retina and tissue engagement all affect fluid movement and traction. The regulatory submission reports bench testing; it does not prove that high cut rate eliminates traction, creates uniformly laminar flow or prevents retinal tears. 11

Choose instruments and maintain a useful view
GaugeRelative access and handlingClinical taskLimit
23G / 25GOriginal larger, more rigid/high-flow exampleComplex TRD, firm membranes or old haemorrhageModel, instruments and surgeon’s task matter; not mandatory for every complex eye.
27GOriginal finer, more flexible exampleMacular pucker, hole or fresh vitreous haemorrhageNot automatically weak, safer or unsuitable; evaluate the actual instrument and view.

08Release traction and use dyes deliberately

Core vitrectomy creates working space; posterior vitreous detachment (PVD) induction aims to separate the posterior cortical vitreous. The optic-disc region is a familiar starting reference, but attachment and the safe plane vary; forceful induction can create retinal breaks. 1 2

Peripheral vitreous management and examination under scleral depression help identify residual traction or breaks. The vitreous base is firmly attached; aggressive attempts to remove every fibre can cause injury and are not a required manoeuvre for every macular hole. 1

The original sutureless example uses a 30–45° scleral tunnel. Wound architecture, gauge and actual leakage determine closure; “sutureless” is a design aim, not a reason to leave a leaking wound or to call every straight entry malpractice. 11

Triamcinolone can make residual vitreous visible, brilliant blue G preferentially stains ILM, and trypan blue is useful for epiretinal membrane staining. These agents have different targets and formulations; “safe for every membrane” is not an adequate product description. 1 12

Indocyanine green (ICG) improves contrast but concentration, exposure, illumination and subretinal contact influence toxicity. The original 30-second rule is not a universal validated safety boundary; use the specific intraocular product information and minimize unnecessary exposure. 1 12

09Select a tamponade and monitor its consequences

Gas tamponade helps support closure, but the choice depends on the operation and the eye. The original SF6 estimate of 3–4 weeks and C3F8 estimate of up to 2 months are not individual clearance dates; published estimates and actual persistence depend on concentration and fill. 1 9

Gas–fluid interfacial properties, contact and buoyancy contribute to tamponade; describing gases simply as having the highest surface tension is not a sufficient selection rule. Longer-acting tamponade for complex detachments or giant retinal tears is a separate decision from routine macular-hole repair. 1 9

The original comparison of 1000 cSt and 5000 cSt silicone oil concerns viscosity and handling. Higher viscosity may resist emulsification under some conditions, but both grades can emulsify; inflammation, impurities, time and ocular movement also matter. 13

In a randomised trial of 100 patients, both low- and high-viscosity oil groups developed emulsification and the difference was not statistically significant. That does not establish equivalence, validate every 1000/5000 cSt product comparison or mean that all proliferative vitreoretinopathy (PVR) requires one viscosity. 13

10Recognize other vitreoretinal emergencies and their evidence limits

Suspected postoperative endophthalmitis requires urgent sampling and antimicrobial treatment coordinated with vitreoretinal care. Do not delay treatment while applying an oversimplified visual-acuity rule. 14 15

EVS randomised 420 patients with endophthalmitis within 6 weeks of cataract surgery or secondary IOL implantation. Its immediate-PPV benefit concerned the light-perception-only subgroup; “≤ light perception” must not be generalized to no-light-perception eyes or every cause and modern setting. 14

The original intravitreal examples are vancomycin 1.0 mg/0.1 ml and ceftazidime 2.25 mg/0.1 ml. The historical ESCRS document lists ceftazidime 2 mg; these source-specific values are not a dilution recipe, and actual treatment requires a checked current local protocol and appropriate pharmacy preparation. 15

For diabetic tractional retinal detachment (TRD), segmentation and delamination release fibrovascular traction. The original optic-disc entry-plane example is a teaching approach, not proof that adhesions are always weakest or dissection safest there; choose the visible plane and avoid traction on adherent retina. 16

A sudden pressure change, loss of red reflex or suspected suprachoroidal bleeding during surgery requires immediate senior assessment and stabilization. The original “Portwine Blood” or “Hafenschlamm” description is not a diagnostic criterion or an instruction for routine high-pressure drainage. 17

Imaging, extent, apposition of detached choroidal elevations, pressure and retinal involvement guide whether and when drainage is considered. The evidence is dominated by heterogeneous observational reports; neither a single drainage technique nor one timing rule is established for every case. 17

Submacular haemorrhage in neovascular age-related macular degeneration (AMD) can prompt consideration of displacement, tPA and anti-VEGF treatment according to timing and anatomy. The original subretinal-tPA/air-or-gas example is one approach, not a universal treatment for blood beneath the macula. 18

STAR randomised 90 people to surgery or pneumatic displacement with tPA and anti-VEGF in both arms; 78 completed the 3-month endpoint. The adjusted visual-gain difference was 1.9 letters (95% CI −11.0–14.9; p=0.767): surgery was not superior, and equivalence was not established. 18

11Use PRP for its retinal indication and titrate the actual exposure

Panretinal photocoagulation (PRP) treats selected proliferative diabetic retinopathy by applying retinal laser outside the central macula. It is distinct from glaucoma laser and from macular-hole surgery; integrate it with the retinal diagnosis and the overall treatment plan. 16 19

The original 250 mW and 95 ms “sweet spot”, and the claim that every pulse <50 ms carries high rupture risk, are not universal settings. Wavelength, spot size, lens, pigmentation, pulse pattern, tissue response and the actual laser instructions change the exposure. 19

MAPASS compared 20 ms multispot with 100 ms single-spot PRP in 40 eyes of 24 people and measured pain. A studied short-pulse regimen contradicts a blanket <50 ms prohibition, but this small trial does not validate every short exposure or prove long-term equivalence. 19

The original inferior-quadrant-first and 3/9-o’clock nerve-sparing points are technique-specific teaching claims. Treat the indicated retinal area with attention to anatomy, burns, bleeding and collateral damage; they do not establish guaranteed permanent mydriasis after any burn at those clock positions. 16 19

12Review the indication, manoeuvre and limitation together

Return to the patient’s actual diagnosis, OCT findings, duration, remaining function and priorities. A defensible explanation connects the observed problem to the next action and its limitations; memorized device figures or exam threats do not replace that reasoning. 1 2

Review the indication, manoeuvre and limitation together
Original topicClinical pointEvidence boundary
EndophthalmitisOriginal Vanco 1 mg / Cefta 2.25 mgUrgent specialist pathway; historical EVS LP-only subgroup is not a universal ≤LP rule or a preparation protocol.
Diabetic TRDFind a visible dissection plane; segmentation/delaminationThe optic-disc example does not guarantee the least adhesion.
27G systemMatch access, stiffness and illumination to the taskAvoid a universal weak-versus-strong gauge hierarchy.
ICG stainingOriginal 30-second teaching rule; ILM visualizationNo universal toxicity threshold; product, concentration, exposure and light matter.
PRPOriginal 250 mW / 95 ms exampleThe <50 ms rupture claim is not a general rule; titrate the actual treatment.
IncisionOriginal 30–45° tunnel exampleCheck the wound and close leakage; no blanket malpractice claim.
Cut rateOriginal up to 20,000 cpmDistinguish effective cuts from drive cycles; no proof of zero traction or universal clinical superiority.
How likely is standard vitrectomy to close an idiopathic macular hole?

Counsel using the actual size, duration, cause, technique and previous surgery. High anatomical closure rates in selected primary holes are not a universal percentage or a guarantee of normal vision.

What positioning is recommended after gas-assisted macular-hole repair?

The team individualizes position and duration for the hole, gas fill, technique and the person’s ability. Explain the uncertain average benefit and keep flight/nitrous-oxide precautions in force while gas remains.

References and access status

  1. 1
    AAO — Idiopathic Macular Hole PPP,2025

    Actual official PDF; selected clinical recommendations/text and extracted tables printed P243–P255 read. Not full methodology, figures or every cited paper. Prose/table pneumatic-vitreolysis tension remains in the evidence record.

  2. 2
    Duker et al. — IVTS classification,2013; PMID24053995

    Complete primary indexed abstract and selected original classification text read; original table1 printed2612 rendered and visually checked for units/inequalities. Not complete paper or all figures; table/body boundary wording differs.

  3. 3
    Lois et al. — FILMS randomized trial,2011; PMID21051731

    Complete primary indexed abstract read through NCBI E-utilities; main paper, protocol and supplements unread.

  4. 4
    Pasu et al. — PIMS randomized trial,2020; PMID32379288

    Complete primary abstract and selected main methods, extracted results/tables and discussion/limitations read. Protocol, SAP, supplements and figures unread; extracted count/conversion anomalies retained for checking.

  5. 5
    Cundy et al. — Cochrane positioning review,2023; PMID37987517

    Complete abstract, extracted summary-of-findings table and selected discussion/risk-of-bias passages read. Search25May2022; not full review or every included trial. Modelled absolute effects and descriptive percentages are different presentations.

  6. 6
    InFlap randomized trial,2024; PMID38131546

    Complete primary indexed abstract read; full methods, report and supplements unread. No equivalence conclusion accepted from nonsignificance.

  7. 7
    Mao et al. — iOCT partial peeling/inferior flap trial,2025; PMID41204608

    Complete primary indexed abstract read; selected small trial, not full main report/protocol or proof of superiority and safety.

  8. 8
    Araujo et al. — amniotic membrane versus ILM flap,2025; PMID40952489

    Complete primary indexed abstract read; full report/registry/protocol unread. Small unmasked single-centre study; baseline imbalance, eye clustering and multiple outcomes require further appraisal.

  9. 9
    RCOphth — intraocular gas/nitrous-oxide safety alert,2018

    Actual official page, gas table and recommendations read; cited case reports not fully read. No fixed individual clearance date inferred.

  10. 10
    RCOphth — day-one review after modern vitrectomy,January2026

    Actual official PDF main pages1–3 and partial extracted flowchart4 read for this review. No new visual flowchart inspection or complete appendix-table review; very-low-certainty evidence and conditional advice.

  11. 11
    FDA — EVA NEXUS K213467,14June2022

    Selected actual regulator letter, device/cutter characteristics and bench-testing passages read. Historical configuration, not current full IFU, clinical superiority or EU authorization; original historical/gauge claims remain unresolved.

  12. 12
    DailyMed — TissueBlue current hosted label,version8/effective20260417

    Main indication, administration, warning, adverse-effect, description and mechanism text read. US label, not German information. Structured quantity/date anomalies stay documented; no silent formulation inference.

  13. 13
    Ratanapakorn et al. — oil-viscosity randomized trial,2020; PMID32103882

    Complete primary indexed abstract read. Exact oil viscosities, outcome denominators and full methods need further access; do not relabel it as every original product comparison.

  14. 14
    Endophthalmitis Vitrectomy Study,1995; PMID7487614

    Complete primary indexed abstract read; full paper/protocol unread. Historical postoperative-cataract population; not a current universal emergency or dosing algorithm.

  15. 15
    ESCRS — endophthalmitis guideline,2013/current linked2018file

    Actual official cover/contents and selected acute-treatment/preparation discussion/table20 printed22–23 read as text. Not full guideline or preparation appendix; original ceftazidime2.25mg differs from this historical2mg source.

  16. 16
    Retained original PPV/TRD/PRP teaching lecture

    Original linked lecture identity retained; video, slides and exact transcript not inspected. Unresolved procedural/anatomical claims are teaching material, not verified recommendations; dedicated cross-page review pending.

  17. 17
    Ribeiro et al. — perioperative SCH systematic review,2024; PMID39169423

    Complete indexed abstract and selected primary introduction/methods read; full tables/reports unread. Mostly case reports/series; no standardized drainage approach.

  18. 18
    Gabrielle et al. — STAR randomized trial,2023; PMID37088447

    Complete primary indexed abstract read through NCBI E-utilities; full paper, protocol and supplements unread. Superiority not shown is not equivalence.

  19. 19
    Muqit et al. — MAPASS report2,2010; PMID20558423

    Complete primary indexed abstract read; direct main report403. Pain-focused small trial; indexed reversed-order confidence interval not silently repaired or reused.

  20. 20
    DOG/BVA/RG — S1 macular hole/VMT,September2022

    Official listing and indexed first scope/definition excerpt read only. Direct registry/PDF anti-bot response; full guideline/correction comparison pending.

  21. 21
    DOG/BVA/RG — erratum,2023; PMID36652000

    Primary publisher identity and correction relationship read; correction body inaccessible in subscription preview. No claim that recommendations or numbers were unchanged.

  22. 22
    RCOphth — idiopathic FTMH guideline,January2025

    Indexed official cover and selected ILM-flap discussion excerpt read only; direct PDF download failed and webopen404. Full final guideline unread;2024draft is not the final document.

Original lecture links